We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – News and Features

News

VGX Pharmaceuticals Submits Device Master File to FDA for CELLECTRA™ Electroporator

The Company has been developing the CELLECTRA™ electroporator as its lead clinical medical device for delivering DNA vaccine and therapy products.
News

NIDDK Scientists Detect new Epitope on HIV-1 Protein gp41 Using AbD Serotec-generated Recombinant Mini-antibody

AbD Serotec has announced the publication of a scientific research paper in Journal of Virology from one of its customers.
News

CLC bio Provides Bioinformatics Solution for Vaccine Target Development to ACE BioSciences

CLC bio will upgrade and expand ACE’s bioinformatics platform to the most up-to-date and relevant software, including protein vaccine target characterization.
News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
News

ImmunoVaccine Technologies Completes Scale-Up of VacciMax® to Commercially Relevant Scale

The work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
News

MedImmune Licenses Reverse Genetics Technology to Novartis

The technology will help Novartis to support the development and construction of new vaccine strains to produce influenza vaccines.
News

Inovio Signs Agreements with National Cancer Institute and International AIDS Vaccine Initiative

The agreements to enhance the potency of DNA-based vaccines against infectious diseases and cancers will utilize Inovio’s DNA delivery technology.
News

Genomic Analysis Uncovers new Targets for HIV Vaccine

Researchers have identified three gene variants in the DNA of 486 HIV infected people that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS.
News

Alphavax Receives $3.6M Award from the National Institute of Allergy and Infectious Diseases

The award supports advanced preclinical studies and manufacturing process development for new adjuvant technologies based on Alphavax’s vector platform.
News

Inovio Biomedical to Present at American Society of Gene Therapy Meeting

The Company will make multiple presentations regarding its electroporation-mediated DNA delivery technology at the meeting.
Advertisement